S. Ausim Azizi, MD, PhD, Matthew T. Moore Chair and Professor of Investigative Neurology, Professor of Neurology, and Professor in the Center for Substance Abuse Research at the Lewis Katz School of Medicine at Temple University, spoke with KYW Newsradio about cluster headaches and the U.S. Food and Drug Administration’s recent approval of the medication Emgality for their treatment.
Temple Faculty Physicians is experiencing technical issues with phone lines. If you are experiencing an emergency, please visit your nearest emergency room. If you would like to schedule an appointment with your provider or have general questions or requests, please contact us by using myTempleHealth.
myTempleHealth
800-TEMPLE-MED
Schedule Appointment
SEARCH TEMPLE HEALTH